• 1
    Carlson RW. NCCN Practice Guidelines in Oncology-Breast Cancer v2.2006. Available at URL: 2006 [accessed September 18, 2006].
  • 2
    Harness JK, Bartlett RH, Saran PA, et al. Developing a comprehensive breast center. Am Surg. 1987; 53: 419423.
  • 3
    Elmore JG, Wells CK, Lee CH, et al. Variability in radiologists' interpretations of mammograms. N Engl J Med. 1994; 331: 14931499.
  • 4
    Sickles EA, Wolverton DE, Dee KE. Performance parameters for screening and diagnostic mammography: specialists and general radiologists. Radiology. 2002; 224: 861869.
  • 5
    Staradub VL, Messenger KA, Hao N, et al. Changes in breast cancer therapy because of pathology second opinions. Ann Surg Oncol. 2002; 9: 982987.
  • 6
    Rakovitch E, Mihai A, Pignol JP, et al. Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ. Breast Cancer Res Treat. 2004; 87: 265272.
  • 7
    Chang JH, Vines E, Bertsch H, et al. The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience. Cancer. 2001; 91: 12311237.
  • 8
    Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347: 12331241.
  • 9
    Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347: 12271232.
  • 10
    Van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial. J Natl Cancer Inst. 2000; 92: 11431150.
  • 11
    Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer. 2003; 98: 697702.
  • 12
    Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data.Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol. 1996; 14: 15581564.
  • 13
    Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis.Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr. 1992; 11: 1925.
  • 14
    Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995; 332: 907911.
  • 15
    Chagpar AB, Studts JL, Scoggins CR, et al. Factors associated with surgical options for breast carcinoma. Cancer. 2006; 106: 14621466.
  • 16
    Lazovich D, Solomon CC, Thomas DB, et al. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer. 1999; 86: 628637.
  • 17
    Aref A, Youssef E, Washington T, et al. The value of postlumpectomy mammogram in the management of breast cancer patients presenting with suspicious microcalcifications. Cancer J Sci Am. 2000; 6: 2527.
  • 18
    Waddell BE, Stomper PC, DeFazio JL, et al. Postexcision mammography is indicated after resection of ductal carcinoma-in-situ of the breast. Ann Surg Oncol. 2000; 7: 665668.
  • 19
    Freedman G, Fowble B, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys. 1999; 44: 10051015.
  • 20
    Freedman G, Hanlon AL, Fowble BL, et al. Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation. J Clin Oncol. 2002; 20: 40154021.
  • 21
    Cabioglu N, Hunt KK, Buchholz TA, et al. Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cancer. 2005; 104: 2029.
  • 22
    Conn CA, McMasters KM, Edwards MJ, Martin RCG. Acceptance of sentinel lymph node biopsy of the breast by all general surgeons in Kentucky. Breast J. 2005; 11: 231235.
  • 23
    Schwartz GF, Hortobagyi GN. Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26–28, 2003, Philadelphia, Pennsylvania. Cancer. 2004; 100: 25122532.
  • 24
    Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997; 15: 24832493.
  • 25
    Mauriac L, MacGrogan G, Avril A, et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124 month median follow-up.Institut Bergonie Bordeaux Group Sein (IBBGS). Ann Oncol. 1999; 10: 4752.
  • 26
    Makris A, Powles TJ, Ashley SE, et al. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol. 1998; 9: 11791184.
  • 27
    Scholl SM, Fourquet A, Asselain B, et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumors considered too large for breast conserving surgery: preliminary results of a randomized trial: S6. Eur J Cancer. 1994; 30A: 645652.
  • 28
    van der Hage JA, van de Velde CJ, Julien JP, et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol. 2001; 19: 42244237.